Alopecia areata
☆ Di encamên 2022-an de Stiftung Warentest ji Almanyayê, razîbûna xerîdar bi ModelDerm tenê ji şêwirmendên telemedicine drav hindik hindiktir bû.
Alopecia areata li ser pişta çermê tê dîtin. Di rewşên gelemperî de, ew ji nişkê ve bi rûyek bi tevahî xweş û mezinahiya 2-3 cm xuya dike.
References
Alopecia areata rewşek e ku pergala berevaniya we êrîşî pelikên porê we dike, û dibe sedema windabûna porê demkî bêyî şop. Ew dikare wekî perçeyên windabûna porê xuya bibe an bandorê li tevahiya serê serê an laşê we bike, li ser 2% ji mirovan di qonaxek jiyana wan de bandor bike. Sûcdarê sereke dixuye ku têkçûnek di parastina xwezayî ya li dora pelikên porê de ye.
Alopecia areata is an autoimmune disorder characterized by transient, non-scarring hair loss and preservation of the hair follicle. Hair loss can take many forms ranging from loss in well-defined patches to diffuse or total hair loss, which can affect all hair-bearing sites. Patchy alopecia areata affecting the scalp is the most common type. Alopecia areata affects nearly 2% of the general population at some point during their lifetime. A breakdown of immune privilege of the hair follicle is thought to be an important driver of alopecia areata.
Alopecia areata is an autoimmune disorder characterized by transient, non-scarring hair loss and preservation of the hair follicle. Hair loss can take many forms ranging from loss in well-defined patches to diffuse or total hair loss, which can affect all hair-bearing sites. Patchy alopecia areata affecting the scalp is the most common type. Alopecia areata affects nearly 2% of the general population at some point during their lifetime. A breakdown of immune privilege of the hair follicle is thought to be an important driver of alopecia areata.
Alopecia areata rewşek e ku pergala berevaniyê êrîşî pelikên porê dike, dibe sedema windabûna porê li ser serê serê xwe û deverên din ên porê laş. Ew li dora 2% ji mirovên cîhanê bandor dike. Digel ku ew dikare di her temenî de çêbibe, ew di zarokan de ji mezinan pirtir e (1. 92% vs. 1. 47%) . Jin, nemaze yên ji 50 salî mezintir, ji mêran bêtir wê biceribînin. Derzkirina kortikosteroidan rasterast li deverên bi bandor encamek çêtir nîşan dide ji sepandina wan a herêmî.
Alopecia areata is an immune-mediated condition leading to non-scarring alopecia of the scalp and other hair-bearing areas of the body. It affects up to 2% of the global population. It can affect all ages, but the prevalence appears higher in children compared to adults (1.92%, 1.47%). A greater incidence has been reported in females than males, especially in patients with late-onset disease, defined as age greater than 50 years. Intralesional injection of corticosteroids has been reported to lead to better responses compared to topical steroids.
Alopecia areata is an immune-mediated condition leading to non-scarring alopecia of the scalp and other hair-bearing areas of the body. It affects up to 2% of the global population. It can affect all ages, but the prevalence appears higher in children compared to adults (1.92%, 1.47%). A greater incidence has been reported in females than males, especially in patients with late-onset disease, defined as age greater than 50 years. Intralesional injection of corticosteroids has been reported to lead to better responses compared to topical steroids.
Tê bawer kirin ku alopecia areata nexweşiyek otoîmmune ye ku bi pergala xweparastinê ya pelikên porê ve girêdayî ye. Mekanîzmaya bingehîn têkçûna laş di naskirina hucreyên xwe de, digel hilweşîna paşîn-navbeynkar a pelika porê vedihewîne.
○ Dermankirin - Dermanên OTC
Hin kesên bi alopecia areata sivik di nav salekê de bêyî dermankirinê baş dibin. Lêbelê, pir kes li ser malperên bêserûber ên li ser serê serê xwe dubare dibin.
#Hydrocortisone cream
○ Demankirinî
Derziyên steroîdan ên hundurîn dermankirina herî bi bandor e. Ger deverên mezin ên çermê bandor bibin, Immunoterapî dikare were ceribandin.
#Triamcinolone intralesional injection
#DPCP immunotherapy